Capra Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Capra Biosciences's estimated annual revenue is currently $930k per year.
- Capra Biosciences's estimated revenue per employee is $77,500
Employee Data
- Capra Biosciences has 12 Employees.
- Capra Biosciences grew their employee count by 33% last year.
Capra Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | Biochemist | Reveal Email/Phone |
3 | Synthetic Biologist | Reveal Email/Phone |
Capra Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3M | 39 | 3% | $28.3M | N/A |
#2 | $1.4M | 9 | -18% | N/A | N/A |
#3 | $5.3M | 34 | 3% | N/A | N/A |
#4 | $31.9M | 206 | 0% | N/A | N/A |
#5 | $0.6M | 4 | -43% | N/A | N/A |
#6 | $4.3M | 55 | -52% | $56.5M | N/A |
#7 | $0.3M | 2 | 0% | N/A | N/A |
#8 | $5.4M | 35 | 21% | N/A | N/A |
#9 | $1.9M | 12 | 0% | N/A | N/A |
#10 | $2.6M | 34 | -11% | $9.8M | N/A |
What Is Capra Biosciences?
Capra Biosciences is developing a new technology that will make the manufacturing of chemicals using biology cost-competitive with petroleum-based products. Significant advances in synthetic biology have been made over the past 20 years, enabling a multitude of products with lower environmental impact and potentially better performance than their petrochemical counterparts. However, cost-competitive large-scale manufacturing of these products remains a significant bottleneck to their adaptation. Our technology tackles this bottleneck through an innovative bioreactor design that promises to significantly reduce end-to-end manufacturing costs.
keywords:N/AN/A
Total Funding
12
Number of Employees
$930k
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | 0% | N/A |
#2 | $1M | 12 | -25% | N/A |
#3 | $2.1M | 12 | -14% | N/A |
#4 | $2M | 13 | 8% | N/A |
#5 | $1.2M | 14 | -12% | N/A |